NIAGEN BIOSCIENCE, INC. Interest Income (Expense), Nonoperating, Net
NIAGEN BIOSCIENCE, INC. (NAGE) reported Interest Income (Expense), Nonoperating, Net of $372.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNonoperatingNet · last filed 2026-08-04
- NIAGEN BIOSCIENCE, INC. interest income (expense), nonoperating, net for the quarter ending 2026-06-30 was $372.00K, a 32.61% decline year-over-year.
- NIAGEN BIOSCIENCE, INC. interest income (expense), nonoperating, net for the quarter ending 2026-03-31 was $375.00K, a 18.30% decline year-over-year.
- NIAGEN BIOSCIENCE, INC. interest income (expense), nonoperating, net for the quarter ending 2025-12-31 was $338.00K, a 9.38% decline year-over-year.
- NIAGEN BIOSCIENCE, INC. interest income (expense), nonoperating, net for the quarter ending 2025-09-30 was $564.00K, a 104.35% increase year-over-year.
- NIAGEN BIOSCIENCE, INC. interest income (expense), nonoperating, net for fiscal 2025 was $1.91M, a 69.44% increase from fiscal 2024.
- NIAGEN BIOSCIENCE, INC. interest income (expense), nonoperating, net for fiscal 2024 was $1.13M, a 70.80% increase from fiscal 2023.
- NIAGEN BIOSCIENCE, INC. interest income (expense), nonoperating, net for fiscal 2023 was $661.00K.
| Period end | Interest Income (Expense), Nonoperating, Net 3 month | Interest Income (Expense), Nonoperating, Net 6 month | Interest Income (Expense), Nonoperating, Net 9 month | Interest Income (Expense), Nonoperating, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $372.00K 10-Q · filed 2026-08-04 | $747.00K 10-Q · filed 2026-08-04 | $1.08M derived: sum of 3 quarters · filed 2026-08-04 | $1.65M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $375.00K 10-Q · filed 2026-05-06 | $713.00K derived: sum of 2 quarters · filed 2026-05-06 | $1.28M derived: sum of 3 quarters · filed 2026-05-06 | $1.83M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $338.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $902.00K derived: sum of 2 quarters · filed 2026-03-04 | $1.45M derived: sum of 3 quarters · filed 2026-08-04 | $1.91M 10-K · filed 2026-03-04 |
| 2025-09-30 | $564.00K 10-Q · filed 2025-11-04 | $1.12M derived: sum of 2 quarters · filed 2026-08-04 | $1.57M 10-Q · filed 2025-11-04 | $1.95M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $552.00K 10-Q · filed 2026-08-04 | $1.01M 10-Q · filed 2026-08-04 | $1.38M derived: sum of 3 quarters · filed 2026-08-04 | $1.66M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $459.00K 10-Q · filed 2026-05-06 | $832.00K derived: sum of 2 quarters · filed 2026-05-06 | $1.11M derived: sum of 3 quarters · filed 2026-05-06 | $1.35M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $373.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $649.00K derived: sum of 2 quarters · filed 2026-03-04 | $890.00K derived: sum of 3 quarters · filed 2026-03-04 | $1.13M 10-K · filed 2026-03-04 |
| 2024-09-30 | $276.00K 10-Q · filed 2025-11-04 | $517.00K derived: sum of 2 quarters · filed 2025-11-04 | $756.00K 10-Q · filed 2025-11-04 | $1.04M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $241.00K 10-Q · filed 2025-08-06 | $480.00K 10-Q · filed 2025-08-06 | $762.00K derived: sum of 3 quarters · filed 2025-08-06 | $950.00K derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $239.00K 10-Q · filed 2025-05-07 | $521.00K derived: sum of 2 quarters · filed 2025-05-07 | $709.00K derived: sum of 3 quarters · filed 2025-05-07 | $834.00K derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | $282.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $470.00K derived: sum of 2 quarters · filed 2025-03-04 | $595.00K derived: sum of 3 quarters · filed 2025-03-04 | $661.00K 10-K · filed 2025-03-04 |
| 2023-09-30 | $188.00K 10-Q · filed 2024-10-31 | $313.00K derived: sum of 2 quarters · filed 2024-10-31 | $379.00K 10-Q · filed 2024-10-31 | |
| 2023-06-30 | $125.00K 10-Q · filed 2024-08-07 | $191.00K 10-Q · filed 2024-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |